Farhan M Syed

Array ( [id] => 1167930 [patent_doc_number] => 06756491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-29 [patent_title] => 'Steroid-activated nuclear receptors and uses therefor' [patent_app_type] => B2 [patent_app_number] => 09/005286 [patent_app_country] => US [patent_app_date] => 1998-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9994 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/756/06756491.pdf [firstpage_image] =>[orig_patent_app_number] => 09005286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1017843 [patent_doc_number] => 06890737 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use' [patent_app_type] => utility [patent_app_number] => 08/928757 [patent_app_country] => US [patent_app_date] => 1997-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 78 [patent_no_of_words] => 27185 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890737.pdf [firstpage_image] =>[orig_patent_app_number] => 08928757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1414104 [patent_doc_number] => 06518014 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Hepadnavirus cores' [patent_app_type] => B1 [patent_app_number] => 08/890735 [patent_app_country] => US [patent_app_date] => 1997-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 3 [patent_no_of_words] => 14922 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518014.pdf [firstpage_image] =>[orig_patent_app_number] => 08890735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1176911 [patent_doc_number] => 06747136 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-06-08 [patent_title] => 'Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen' [patent_app_type] => B2 [patent_app_number] => 08/844215 [patent_app_country] => US [patent_app_date] => 1997-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 28 [patent_no_of_words] => 24369 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/747/06747136.pdf [firstpage_image] =>[orig_patent_app_number] => 08844215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4535616 [patent_doc_number] => 07888458 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-02-15 [patent_title] => 'Diagnostics and therapy of epstein-barr virus in autoimmune disorders' [patent_app_type] => utility [patent_app_number] => 08/781296 [patent_app_country] => US [patent_app_date] => 1997-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 23 [patent_no_of_words] => 15847 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888458.pdf [firstpage_image] =>[orig_patent_app_number] => 08781296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1373727 [patent_doc_number] => 06555114 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-29 [patent_title] => 'Immunodominant human T-cell epitopes of hepatitis C virus' [patent_app_type] => B1 [patent_app_number] => 08/635886 [patent_app_country] => US [patent_app_date] => 1996-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 53528 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/555/06555114.pdf [firstpage_image] =>[orig_patent_app_number] => 08635886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1366628 [patent_doc_number] => 06562340 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-13 [patent_title] => 'Enzyme feed additive and animal feed including it' [patent_app_type] => B1 [patent_app_number] => 08/507362 [patent_app_country] => US [patent_app_date] => 1995-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 16303 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/562/06562340.pdf [firstpage_image] =>[orig_patent_app_number] => 08507362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6362670 [patent_doc_number] => 20020058783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'FIBROBLAST GROWTH FACTOR 14' [patent_app_type] => new [patent_app_number] => 08/462159 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12697 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058783.pdf [firstpage_image] =>[orig_patent_app_number] => 08462159 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1473120 [patent_doc_number] => 06387365 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Combination therapy for chronic hepatitis C infection' [patent_app_type] => B1 [patent_app_number] => 08/444584 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1267 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387365.pdf [firstpage_image] =>[orig_patent_app_number] => 08444584 [rel_patent_id] =>[rel_patent_doc_number] =>)